Home  /  Resource Library  /  Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study

Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study

Results of a study investigating obinutuzumab, lenalidomide and venetoclax for first line treatment of follicular lymphoma.